BAX and Alzheimer disease: As demonstrated in Fig. 10, the AD-untreated group showed significant (p < 0.05) higher levels of BAX, BAX/BCL2 ratio, and caspase-3, while it showed significant (p < 0.05) lower levels of BCL2 than the normal control group.